Vavricka John [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
01/31/2022	Atea Pharmaceuticals, Inc.	AVIR	Grant	Stock Option (Right to Buy)	135k	$7.14	$963.9k		01/31/2022
01/29/2021	Atea Pharmaceuticals, Inc.	AVIR	Grant	Stock Option (Right to Buy)	117.3k	$73.00	$8.6M		01/29/2021
11/03/2020	Atea Pharmaceuticals, Inc.	AVIR	Conversion	Common Stock	82.5k	$0.00	$0	Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust	11/03/2020
11/03/2020	Atea Pharmaceuticals, Inc.	AVIR	Conversion	Series B Convertible Preferred Stock	82.5k	$0.00	$0	Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust	11/03/2020